Figure 2 — Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma

Navigate

Research Paper|Volume 16, Issue 3|pp. 2679–2701

Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma

Back to articleFigure 2(2 of 7)

100%

Figure 2.CRGs expression in progression of ccRCC. (A) Expression of CRGs in normal tissues and tumors samples from GSE40435 by (B) stage and (C) sex.

Figure 2 — Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma | Aging